Skip to main content
Premium Trial:

Request an Annual Quote

German Firms Collaborate on Sepsis MDx Test

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – German firms SIRS-Lab and Analytik Jena today announced a collaboration focused on sepsis diagnostics.

Under the deal, AJ Innuscreen, a subsidiary of Analytik Jena, will provide SIRS-Lab a platform for the automated isolation of nucleic acids and associated reagents. The products from Analytik Jena are tailored for the fully automated extraction of DNA in whole blood samples. A clinical study is underway to validate a PCR-based test being developed, which "should create the conditions to start marketing our sepsis diagnostics very soon," said Barbara Staehelin, CEO of SIRS-Lab, in a statement.

Axel Kunz, manager of corporate communications for SIRS-lab added that the goal is to get a CE-IVD mark for the test.

Financial terms of the deal were not disclosed.

Both Analytik-Jena and SIRS-Lab are based in Jena, Germany. Analytik-Jena provides systems for analytic measurements. SIRS-Lab is a molecular diagnostics firm focused on sepsis and other life-threatening infections.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.